<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37041478</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2415</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>11</Day></PubDate></JournalIssue><Title>BMC ophthalmology</Title><ISOAbbreviation>BMC Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Analysis of choroidal thickness in juvenile systemic lupus erythematosus and its correlation with laboratory tests.</ArticleTitle><Pagination><StartPage>148</StartPage><MedlinePgn>148</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">148</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12886-023-02906-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The aim of this study is to investigate the alterations of choroidal thickness (CT) in juvenile systemic lupus erythematosus (JSLE) using enhanced depth imaging optical coherence tomography (EDI-OCT). We also aimed to assess whether CT parameters correlated with systemic health status in JSLE patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">JSLE patients and age- and sex-matched healthy subjects were recruited. A detailed ophthalmological examination was applied to all participants. CT measurements were acquired in the macular region using EDI-OCT. Moreover, a spectrum of laboratory tests was examined to evaluate the systemic conditions, and the Th1/Th2/Th17/Treg cytokine profiles in the peripheral blood were also analyzed in JSLE group.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 45 JSLE patients with no visual impairment and 50 healthy individuals were enrolled in the study. CT values in the macular region were decreased in JSLE patients when compared with healthy controls, even adjusting for age, axial length and refraction. There were no significant correlations between CT and cumulative dose of hydroxychloroquine or duration of hydroxychloroquine use (all P&#x2009;&gt;&#x2009;0.05). The average macular, temporal and subfoveal CT in JSLE group was negatively correlated with IL-6 and IL-10 (all P&#x2009;&lt;&#x2009;0.05), but had no significant correlations with other laboratory results (all P&#x2009;&gt;&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">JSLE patients without ocular involvement may have significant variations in choroidal thickness at the macular area. Choroidal alterations might be associated with the systemic cytokine profiles in JSLE.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ru</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jinping</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Zhongjing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China. ahwwlzj@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Lanfang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China. clf530417@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China. Zhanglin1187@renji.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Ophthalmol</MedlineTA><NlmUniqueID>100967802</NlmUniqueID><ISSNLinking>1471-2415</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="Y">Hydroxychloroquine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002829" MajorTopicYN="N">Choroid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041623" MajorTopicYN="N">Tomography, Optical Coherence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012029" MajorTopicYN="N">Refraction, Ocular</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Choroidal thickness</Keyword><Keyword MajorTopicYN="N">Cytokine</Keyword><Keyword MajorTopicYN="N">Optical coherence tomography</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare that there was no funding support or conflicting interests regarding the publication of this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>23</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37041478</ArticleId><ArticleId IdType="pmc">PMC10088154</ArticleId><ArticleId IdType="doi">10.1186/s12886-023-02906-4</ArticleId><ArticleId IdType="pii">10.1186/s12886-023-02906-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiriakidou M, Ching C. Systemic lupus erythematosus. Ann Intern Med. 2020;172(11):ITC81&#x2013;ITC96. doi: 10.7326/AITC202006020.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/AITC202006020</ArticleId><ArticleId IdType="pubmed">32479157</ArticleId></ArticleIdList></Reference><Reference><Citation>Durcan L, O&#x2019;Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet. 2019;393(10188):2332&#x2013;43. doi: 10.1016/S0140-6736(19)30237-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30237-5</ArticleId><ArticleId IdType="pubmed">31180030</ArticleId></ArticleIdList></Reference><Reference><Citation>Preble J, Silpa-archa S, Foster C. Ocular involvement in systemic lupus erythematosus. Curr Opin Ophthalmol. 2015;26(6):540&#x2013;5. doi: 10.1097/ICU.0000000000000209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ICU.0000000000000209</ArticleId><ArticleId IdType="pubmed">26367085</ArticleId></ArticleIdList></Reference><Reference><Citation>Silpa-Archa S, Lee J, Foster C. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016;100(1):135&#x2013;41. doi: 10.1136/bjophthalmol-2015-306629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2015-306629</ArticleId><ArticleId IdType="pubmed">25904124</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham E, Tabbara K, Zierhut M. Systemic lupus erythematosus and the eye. Ocul Immunol Inflamm. 2018;26(8):1143&#x2013;5. doi: 10.1080/09273948.2018.1539589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2018.1539589</ArticleId><ArticleId IdType="pubmed">30452316</ArticleId></ArticleIdList></Reference><Reference><Citation>Dammacco R. Systemic lupus erythematosus and ocular involvement: an overview. Clin Exp Med. 2018;18(2):135&#x2013;49. doi: 10.1007/s10238-017-0479-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-017-0479-9</ArticleId><ArticleId IdType="pubmed">29243035</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiou Y, Chang Y, Su C, Li T, Lai C, Hwang D, Wu F, Chang Y. Risks of posterior segment ocular ischaemic events in patients with systemic lupus erythematosus: a population-based cohort study in Taiwan.Br J Ophthalmol. 2022; bjophthalmol-2022-321653.</Citation><ArticleIdList><ArticleId IdType="pubmed">35922126</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung YR, Cho EH, Jang S, Lee SY, Lee ES, Lee K. Choroidal thickness indicates subclinical ocular and systemic inflammation in eyes with Beh&#xe7;et&#x2019;s disease without active inflammation. Korean J Ophthalmol. 2018;32(4):290&#x2013;5. doi: 10.3341/kjo.2017.0139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3341/kjo.2017.0139</ArticleId><ArticleId IdType="pmc">PMC6085188</ArticleId><ArticleId IdType="pubmed">30091307</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltmr A, Lightman S, Tomkins-Netzer O. Examining the choroid in ocular inflammation: a focus on enhanced depth imaging. J Ophthalmol. 2014; 2014: 459136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4082870</ArticleId><ArticleId IdType="pubmed">25024846</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolba D, El-Fayoumi D, Abdelaziz M, Nabih M. Fluorescein angiographic findings in patients with active systemic lupus erythematosus. Ocul Immunol Inflamm. 2017;25(6):884&#x2013;90. doi: 10.1080/09273948.2016.1192653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2016.1192653</ArticleId><ArticleId IdType="pubmed">27437561</ArticleId></ArticleIdList></Reference><Reference><Citation>Gharbiya M, Pecci G, Baglio V, Gargiulo A, Allievi F, Balacco-Gabrieli C. Indocyanine green angiographic findings for patients with systemic lupus erythematosus nephropathy. Retina (Philadelphia Pa) 2006;26(2):159&#x2013;64. doi: 10.1097/00006982-200602000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006982-200602000-00006</ArticleId><ArticleId IdType="pubmed">16467671</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Kim S, Kim G. Microvascular findings in patients with systemic lupus erythematosus assessed by fundus photography with fluorescein angiography. Clin Exp Rheumatol. 2013;31(6):871&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24021339</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrejen S, Spaide R. Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol. 2013;58(5):387&#x2013;429. doi: 10.1016/j.survophthal.2012.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.survophthal.2012.12.001</ArticleId><ArticleId IdType="pubmed">23916620</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy D, Kamphuis S. Systemic lupus erythematosus in children and adolescents. Pediatr Clin North Am. 2012;59(2):345&#x2013;64. doi: 10.1016/j.pcl.2012.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcl.2012.03.007</ArticleId><ArticleId IdType="pmc">PMC3348509</ArticleId><ArticleId IdType="pubmed">22560574</ArticleId></ArticleIdList></Reference><Reference><Citation>Malattia C, Martini A. Paediatric-onset systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2013;27(3):351&#x2013;62. doi: 10.1016/j.berh.2013.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2013.07.007</ArticleId><ArticleId IdType="pubmed">24238692</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarr T, D&#xe9;rfalvi B, Gy&#x151;ri N, Sz&#xe1;nt&#xf3; A, Siminszky Z, Malik A, Szab&#xf3; A, Szegedi G, Zeher M. Similarities and differences between pediatric and adult patients with systemic lupus erythematosus. Lupus. 2015;24(8):796&#x2013;803. doi: 10.1177/0961203314563817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314563817</ArticleId><ArticleId IdType="pubmed">25516474</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E, Lythgoe H, Midgley A, Beresford M, Hedrich C. Juvenile-onset systemic lupus erythematosus: update on clinical presentation, pathophysiology and treatment options. Clin Immunol. 2019;209:108274. doi: 10.1016/j.clim.2019.108274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2019.108274</ArticleId><ArticleId IdType="pubmed">31678365</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, D&#xf6;rner T, Johnson S. Advances in SLE classification criteria.J Autoimmun. 2022;102845.</Citation><ArticleIdList><ArticleId IdType="pubmed">35725680</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman D, Iba&#xf1;ez D, Urowitz M. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">11838846</ArticleId></ArticleIdList></Reference><Reference><Citation>Hysa E, Cutolo C, Gotelli E, Paolino S, Cimmino M, Pacini G, Pizzorni C, Sulli A, Smith V, Cutolo M. Ocular microvascular damage in autoimmune rheumatic diseases: the pathophysiological role of the immune system. Autoimmun Rev. 2021;20(5):102796. doi: 10.1016/j.autrev.2021.102796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102796</ArticleId><ArticleId IdType="pubmed">33722750</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie R, Qiu B, Chhablani J, Zhang X. Evaluation of choroidal thickness using optical coherent tomography: a review. Front Med (Lausanne) 2021;8:783519. doi: 10.3389/fmed.2021.783519.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.783519</ArticleId><ArticleId IdType="pmc">PMC8677938</ArticleId><ArticleId IdType="pubmed">34926529</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinese Rheumatology Association, National Clinical Research Center for Dermatologic and Immunologic Diseases, Chinese Systemic Lupus Erythematosus Treatment and Research Group 2020 chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus. Chin J Intern Med. 2020;59(3):172&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">32146743</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EMD, Lythgoe H, Midgley A, Beresford MW, Hedrich CM. Juvenile-onset systemic lupus erythematosus: update on clinical presentation, pathophysiology and treatment options. Clin Immunol. 2019;209:108274. doi: 10.1016/j.clim.2019.108274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2019.108274</ArticleId><ArticleId IdType="pubmed">31678365</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong S, He X, Deng J, Lv M, Jin J, Sun S, Yao C, Zhu J, Zou H, Xu X. Choroidal thickness in 3001 chinese children aged 6 to 19 years using swept-source OCT. Sci Rep. 2017;7:45059. doi: 10.1038/srep45059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep45059</ArticleId><ArticleId IdType="pmc">PMC5361145</ArticleId><ArticleId IdType="pubmed">28327553</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner M, Esteban-Ortega M, Mu&#xf1;oz-Fern&#xe1;ndez S. Choroidal and retinal thickness in systemic autoimmune and inflammatory diseases: a review. Surv Ophthalmol. 2019;64(6):757&#x2013;69. doi: 10.1016/j.survophthal.2019.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.survophthal.2019.04.007</ArticleId><ArticleId IdType="pubmed">31034855</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zdal P, Tugal-Tutkun I. Choroidal involvement in systemic vasculitis: a systematic review. J Ophthalmic Inflamm Infect. 2022;12(1):14. doi: 10.1186/s12348-022-00292-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12348-022-00292-4</ArticleId><ArticleId IdType="pmc">PMC8980189</ArticleId><ArticleId IdType="pubmed">35377017</ArticleId></ArticleIdList></Reference><Reference><Citation>A&#x11f;&#x131;n A, Kaday&#x131;f&#xe7;&#x131;lar S, S&#xf6;nmez H, Baytaro&#x11f;lu A, Demir S, Sa&#x11f; E, &#xd6;zen S, Eldem B. Evaluation of choroidal thickness, choroidal vascularity index and peripapillary retinal nerve fiber layer in patients with juvenile systemic lupus erythematosus. Lupus. 2019;28(1):44&#x2013;50. doi: 10.1177/0961203318814196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203318814196</ArticleId><ArticleId IdType="pubmed">30466353</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C, Cheong K. Macular choroidal thicknesses in healthy adults&#x2013;relationship with ocular and demographic factors. Invest Ophthalmol Vis Sci. 2014;55(10):6452&#x2013;8. doi: 10.1167/iovs.13-13771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.13-13771</ArticleId><ArticleId IdType="pubmed">25228543</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty R, Read SA, Collins MJ. Diurnal variations in axial length, choroidal thickness, intraocular pressure, and ocular biometrics. Invest Ophthalmol Vis Sci. 2011;52(8):5121&#x2013;9. doi: 10.1167/iovs.11-7364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.11-7364</ArticleId><ArticleId IdType="pubmed">21571673</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CS, Ouyang Y, Ruiz H, Sadda SR. Diurnal variation of choroidal thickness in normal healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(1):261&#x2013;6. doi: 10.1167/iovs.11-8782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.11-8782</ArticleId><ArticleId IdType="pubmed">22167095</ArticleId></ArticleIdList></Reference><Reference><Citation>Altinkaynak H, Duru N, Uysal B, Erten &#x15e;, K&#xfc;rkc&#xfc;o&#x11f;lu P, Y&#xfc;ksel N, Duru Z, &#xc7;a&#x11f;&#x131;l N. Choroidal thickness in patients with systemic lupus erythematosus analyzed by spectral-domain optical coherence tomography. Ocul Immunol Inflamm. 2016;24(3):254&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">26154112</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias-Santos A, Tavares Ferreira J, Pinheiro S, Cunha J, Alves M, Papoila A, Moraes-Fontes M, Proen&#xe7;a R. Choroidal thickness changes in systemic lupus erythematosus patients. Clin Ophthalmol. 2019;13:1567&#x2013;78. doi: 10.2147/OPTH.S219347.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OPTH.S219347</ArticleId><ArticleId IdType="pmc">PMC6708390</ArticleId><ArticleId IdType="pubmed">31933520</ArticleId></ArticleIdList></Reference><Reference><Citation>Invernizzi A, dell&#x2019;Arti L, Leone G, Galimberti D, Garoli E, Moroni G, Santaniello A, Agarwal A, Viola F. Drusen-like deposits in young adults diagnosed with systemic lupus erythematosus. Am J Ophthalmol. 2017;175:68&#x2013;76. doi: 10.1016/j.ajo.2016.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2016.11.014</ArticleId><ArticleId IdType="pubmed">27939560</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga J, Rothwell R, Oliveira M, Rodrigues D, Fonseca S, Varandas R, Ribeiro L. Choroid thickness profile in patients with lupus nephritis. Lupus. 2019;28(4):475&#x2013;82. doi: 10.1177/0961203319828525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203319828525</ArticleId><ArticleId IdType="pubmed">30755143</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan Salah S, Makled H, ElMekawey H, Elgengehy F, Medhat B, Abdel Baki N, Koptan D. Choroidal thickness and microRNA146 in lupus nephritis patients. Clin Ophthalmol. 2020;14:1503&#x2013;10. doi: 10.2147/OPTH.S254288.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OPTH.S254288</ArticleId><ArticleId IdType="pmc">PMC7276375</ArticleId><ArticleId IdType="pubmed">32581507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee I, Marshall B, Ranganathan P, Eisen S, Rajagopal R, Kim A, Li T. Choroidal thickness in lupus nephritis. Lupus. 2020;29(2):205&#x2013;9. doi: 10.1177/0961203319898765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203319898765</ArticleId><ArticleId IdType="pmc">PMC6992474</ArticleId><ArticleId IdType="pubmed">31924146</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira C, Beato J, Falc&#xe3;o M, Brand&#xe3;o E, Falc&#xe3;o-Reis F, Carneiro &#xc2;. Choroidal thickness in multisystemic autoimmune diseases without ophthalmologic manifestations. Retina. 2017;37(3):529&#x2013;35. doi: 10.1097/IAE.0000000000001193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IAE.0000000000001193</ArticleId><ArticleId IdType="pubmed">27429379</ArticleId></ArticleIdList></Reference><Reference><Citation>I&#x15f;&#x131;k M, Akmaz B, Akay F, G&#xfc;ven Y, Solmaz D, Gercik &#xd6;, Kabaday&#x131; G, Kurut &#x130;, Akar S. Evaluation of subclinical retinopathy and angiopathy with OCT and OCTA in patients with systemic lupus erythematosus. Int Ophthalmol. 2021;41(1):143&#x2013;50. doi: 10.1007/s10792-020-01561-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10792-020-01561-8</ArticleId><ArticleId IdType="pubmed">32851556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn S, Ryu S, Joung J, Lee B. Choroidal thinning associated with hydroxychloroquine retinopathy. Am J Ophthalmol. 2017;183:56&#x2013;64. doi: 10.1016/j.ajo.2017.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2017.08.022</ArticleId><ArticleId IdType="pubmed">28890078</ArticleId></ArticleIdList></Reference><Reference><Citation>Forte R, Haulani H, Dyrda A, J&#xfc;rgens I. Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests. Br J Ophthalmol. 2021;105(9):1297&#x2013;301. doi: 10.1136/bjophthalmol-2018-313679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2018-313679</ArticleId><ArticleId IdType="pubmed">30842084</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulut M, Ak&#x131;dan M, G&#xf6;zkaya O, Erol M, Cengiz A, &#xc7;ay H. Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations. Graefes Arch Clin Exp Ophthalmol. 2018;256(11):2075&#x2013;81. doi: 10.1007/s00417-018-4117-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-018-4117-3</ArticleId><ArticleId IdType="pubmed">30159602</ArticleId></ArticleIdList></Reference><Reference><Citation>Dima A, Jurcut C, Chasset F, Felten R, Arnaud L. Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge. Ther Adv Musculoskelet Dis. 2022;14:1759720X211073001. doi: 10.1177/1759720X211073001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759720X211073001</ArticleId><ArticleId IdType="pmc">PMC8848057</ArticleId><ArticleId IdType="pubmed">35186126</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung S, Park J, Park D, You Y, Yan P. The effect of systemic and topical ophthalmic medications on choroidal thickness: a review. Br J Clin Pharmacol. 2022;88(6):2673&#x2013;85. doi: 10.1111/bcp.15237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.15237</ArticleId><ArticleId IdType="pubmed">35060151</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenan-Barrett J, Doolan G, Shah D, Virdee S, Robinson G, Choida V, Gak N, de Gruijter N, Rosser E, Al-Obaidi M, et al. Biomarkers associated with organ-specific involvement in juvenile systemic lupus erythematosus. Int J Mol Sci. 2021;22(14):7619. doi: 10.3390/ijms22147619.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22147619</ArticleId><ArticleId IdType="pmc">PMC8306911</ArticleId><ArticleId IdType="pubmed">34299237</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcanti A, Santos R, Mesquita Z, Duarte A, Lucena-Silva N. Cytokine profile in childhood-onset systemic lupus erythematosus: a cross-sectional and longitudinal study. Braz J Med Biol Res. 2017;50(4):e5738. doi: 10.1590/1414-431x20175738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1414-431x20175738</ArticleId><ArticleId IdType="pmc">PMC5423750</ArticleId><ArticleId IdType="pubmed">28380214</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>